|
 A New Concept in Therapy Response Assessment Medical Imaging plays an important role in oncology therapy assessment. As clinicians shift cancer treatment to more personalized, adaptive programs, increased needs have developed for the visualization of tumour response to specific therapies.
In particular, clinicians require solutions that allow fast and efficient evaluation of tumour activity; fast in the sense of time required to identify changes in tumour activity; efficient in the sense of physical steps required to generate meaningful quantitative information from medical images.
Cedara I-Response is a leading edge workstation specifically designed for fast and efficient analysis of tumour response. Supporting multiple modalities with a flexible workflow, Cedara I-Response sets a new standard for therapeutic assessment in cancer care. Automatically generate a variety of quantitative calculations, compare tumour activity at multiple time points and visualize therapy response in individual, configurable layouts with this powerful software application.
Cedara I-Response boosts productivity in patient diagnosis and follow-up assessments as well as research through intelligent workflow and sophisticated image processing for coregistration with prior studies and tumour segmentation.
Functional Diffusion Mapping Cedara I-Response features the patented technology of functional Diffusion Mapping (ƒDM). Based on landmark work at the University of Michigan, this method allows healthcare professionals to visualize changes in tumour tissue resulting from cellular and metabolic mechanisms. Functional Diffusion Mapping has the potential to precisely monitor the early impact of anti-cancer drugs and radiation therapy. By giving radiologists, oncologists, researchers and others a sophisticated tool to study tumour activity at both the cellular and anatomical level, Cedara I-Response provides a foundation on which fast, efficient and personalized cancer treatment planning can develop.
|
